Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Genome Research Limited (GRL) is seeking two Advanced Research Assistants to contribute to a groundbreaking CRISPR genome editing project aimed at developing novel gene therapy for Beta Thalassemia. Candidates will work in a collaborative environment and engage in cutting-edge scientific research, performing genome editing experiments and analyzing outcomes using sophisticated techniques. This role presents an opportunity to impact human health positively and gain vital experience in translational research.
Advanced Research Assistant – CRISPR-Based Gene Editing for Beta Thalassemia treatment page is loaded
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
We are seeking two highly motivated Advanced Research Assistants to join an interdisciplinary team working on a cutting-edge CRISPR-based genome editing project at the Wellcome Sanger Institute. In collaboration with the MRC, The project aims to generate proof-of-concept data for a novel gene therapy platform to treat Beta Thalassemia.
Unlike traditional gene therapies that correct individual mutations, our patented technology (UK Patent Application No. 20250002943) enables one-step replacement of the entire defective gene locus with a wild-type version. This approach offers a scalable solution that has the potential to transform the gene therapy landscape.
We are looking to recruit two fixed-term positions as Advanced Research Assistants for up to 9 months (until 28 September 2026). For internal applicants, this fixed-term role is available as a secondment opportunity.
The postholders will work under the supervision of Dr Valentina Migliori, in the Cellular and Gene Editing Research group led by Andrew Bassett in collaboration with MRC, leveraging the Wellcome Sanger Institute’s world-class expertise in genome engineering, iPSC biology, and sequencing technologies.
About the role
You will work independently within a collaborative team of Technical Specialists, Postdocs and Staff Scientists. You will use human induced pluripotent stem cells (hiPSCs) to optimise the editing system and evaluate its efficiency and specificity using techniques such as flow cytometry (FACS), advanced long-read sequencing, ddPCR, and drug-based selection. The goal is to generate robust, high-quality data to support the potential launch of a biotech spin-out company that could provide opportunities for further career development. If successful, this platform will be expanded to additional genetic loci and diseases.
Your key responsibilities will include:
About you
You will have hands-on experience in cell culture and molecular biology, ideally with prior exposure to genome editing technologies such as CRISPR/Cas9. Experience working with human induced pluripotent stem cells (hiPSCs) or other primary cell systems will be highly advantageous.
You are curious, detail-oriented, and motivated by the potential to translate cutting-edge science into impactful therapies. You enjoy working in a fast-paced, collaborative environment and can manage multiple priorities effectively. Strong organisational, communication and record-keeping skills are essential, as is a willingness to learn and adapt new experimental approaches.
This role offers an excellent opportunity to contribute to an innovative therapeutic platform at an early stage, and to gain experience in translational research within a world-class scientific environment. All appropriate training will be provided to support your development and success in the role.
About Us
We are the Cellular and Gene Editing Research team within Scientific Operations at the Wellcome Sanger Institute, led by Dr Andrew Bassett. Our team specialises in developing and applying cutting-edge technologies in genome engineering, single-cell analysis, and spatial biology to enable high-impact research. While we work across a diverse portfolio of projects, this particular role is embedded within a new translational initiative focused on pioneering genome engineering technologies for therapeutic purposes. As part of our collaborative and innovation-driven environment, you will work closely with both internal and external partners, including the MRC, to generate proof-of-concept data for whole gene replacement strategies in human stem cells.
Knowledge, skills, and experience required:
E = Essential, D = Desirable
Other Information:
Please include a CV and covering letter with your application describing how you meet the requirements of the role described.
Salary range (depending on skills and experience) : £32,691 - £39,230
Closing Date: 6th June 2025
Applications may close early if high volumes of suitable applications are received.
Hybrid Working at Wellcome Sanger:
We recognise that there are many benefits to Hybrid Working; including an improved work-life balance, with more focused time, as well as the ability to organise working time so that collaborative opportunities and team discussions are facilitated on campus. The hybrid working arrangement will vary for different roles and teams. The nature of your role and the type of work you do will determine if a hybrid working arrangement is possible.
Equality, Diversity and Inclusion:
We aim to attract, recruit, retain and develop talent from the widest possible talent pool, thereby gaining insight and access to different markets to generate a greater impact on the world. We have a supportive culture with the following staff networks, LGBTQ+, Parents and Carers, Disability and Race Equity to bring people together to share experiences, offer specific support and development opportunities and raise awareness. The networks are also a place for allies to provide support to others.
We want our people to be whoever they want to be because we believe people who bring their best selves to work, do their best work. That’s why we’re committed to creating a truly inclusive culture at Sanger Institute. We will consider all individuals without discrimination and are committed to creating an inclusive environment for all employees, where everyone can thrive.
Our Benefits:
We are proud to deliver an awarding campus-wide employee wellbeing strategy and programme. The importance of good health and adopting a healthier lifestyle and the commitment to reduce work-related stress is strongly acknowledged and recognised at Sanger Institute.
Sanger Institute became a signatory of the International Technician Commitment initiative In March 2018. The Technician Commitment aims to empower and ensure visibility, recognition, career development and sustainability for technicians working in higher education and research, across all disciplines.
Life at the Sanger Institute is unique. We are tackling some of the most difficult challenges in genomic research. Our people are shaping the future by delivering life-changing science with the reach, scale, and creativity to solve some of humanity’s greatest challenges. We aim to attract, recruit, retain and develop talent from the widest possible talent pool, thereby gaining insight and access to different markets to generate a greater impact on the world.